Q2 2022 Vistin Pharma ASA Earnings Call Transcript
Good day, and thank you for standing by. Welcome to the Vistin Pharma Quarterly Report Q2 202 Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded.
I would now like to turn the conference over to your speaker today, Alexander Karlsen. Please go ahead.
Thank you, and good morning, everyone. Welcome to Vistin Pharma's Second Quarter and First Half presentation. Today's presentators will be myself, Alexander Karlsen, the CFO. And with me, I have Magnus Tolleshaug, the CCO and the interim CEO. I will now hand it over to you, Magnus.
Thank you, Alexander. I will go through the highlights of the second quarter and year-to-date 2022 results. The second quarter ended with a revenue of NOK 69 million versus NOK 67 million in Q2 2021, which represents a 3% increase. Due to the Metformin Expansion Project, ramp-up activities,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |